Literature DB >> 14980979

Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries.

Joseph Zacharia1, Chris Hillier, Allan MacDonald.   

Abstract

1. The alpha(1)-adrenoceptor subtypes involved in responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries were characterised using a small vessel myograph, with antagonists prazosin (nonsubtype selective), 5-methyl-urapidil (alpha(1A)-selective), BMY 7378 (alpha(1D)-selective) and the alkylating agent chloroethylclonidine (preferential for alpha(1B)-). 2. Prazosin and 5-methyl-urapidil produced rightward shifts of the exogenous noradrenaline concentration - response curve (CRC) with pA(2) values of 9.2 and 9.1 respectively, in agreement with the presence of alpha(1A)-adrenoceptors. BMY 7378 (1 microm) shifted the noradrenaline CRC with an apparent pK(B) of 6.7, in agreement with the presence of alpha(1A)-, but not alpha(1D)-, adrenoceptors. Chloroethylclonidine at 1 microm had no effect and at 10 microm produced only a small reduction (c. 20%) in the maximum response to noradrenaline, indicating little, if any, contribution from alpha(1B)-adrenoceptors. 3. Responses of the rat femoral resistance arteries to electrical field stimulation (EFS) at 5-30 Hz for 10 s and 0.05 ms pulse width were principally due to alpha(1)-adrenoceptor stimulation. Prazosin and 5-methyl-urapidil inhibited EFS-mediated responses with pIC(50)s of 9.3 and 8.2, respectively, consistent with the alpha(1A)-adrenoceptor being the predominant subtype. Responses to EFS at 10-30 Hz were relatively insensitive to BMY 7378 (pIC(50), 6.5-6.7), while responses to 5 Hz were inhibited with a significantly higher pIC(50) of 8.02, suggesting the contribution of alpha(1D)-adrenoceptors. Chloroethylclonidine had no effect on responses to EFS, ruling out the contribution of an alpha(1B)-subtype. In the presence of cocaine, the predominant subtype involved in responses to EFS was the alpha(1A)-adrenoceptor, with a contribution from alpha(1D)-adrenoceptors at low frequency, as seen in the absence of cocaine. However, there was also a significant increase in the sensitivity to BMY 7378 at higher frequencies, suggesting that a further small alpha(1D)-adrenoceptor component may be uncovered in the presence of cocaine. 5. The present study has shown a predominant role of the alpha(1A)-adrenoceptor in contractions due to exogenous noradrenaline and to neurally released noradrenaline in rat femoral resistance arteries. alpha(1D)-Adrenoceptors are not involved in responses to exogenous noradrenaline but appear to be activated by neurally released noradrenaline at a low frequency of stimulation and at higher frequencies in the presence of neuronal-uptake blockade.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980979      PMCID: PMC1574265          DOI: 10.1038/sj.bjp.0705690

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.

Authors:  P Leff; B E Wood; S E O'Connor
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.

Authors:  A P Ford; N F Arredondo; D R Blue; D W Bonhaus; J Jasper; M S Kava; J Lesnick; J R Pfister; I A Shieh; R L Vimont; T J Williams; J E McNeal; T A Stamey; D E Clarke
Journal:  Mol Pharmacol       Date:  1996-02       Impact factor: 4.436

Review 3.  Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure.

Authors:  H M Vargas; A J Gorman
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

Review 4.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

Authors:  J P Hieble; D B Bylund; D E Clarke; D C Eikenburg; S Z Langer; R J Lefkowitz; K P Minneman; R R Ruffolo
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

5.  BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors.

Authors:  A S Goetz; H K King; S D Ward; T A True; T J Rimele; D L Saussy
Journal:  Eur J Pharmacol       Date:  1995-01-16       Impact factor: 4.432

6.  Contributions of alpha 1-adrenoceptors, alpha 2-adrenoceptors and P2x-purinoceptors to neurotransmission in several rabbit isolated blood vessels: role of neuronal uptake and autofeedback.

Authors:  A MacDonald; C J Daly; J M Bulloch; J C McGrath
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

7.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

8.  Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle.

Authors:  I Muramatsu; T Ohmura; S Kigoshi; S Hashimoto; M Oshita
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

9.  Characterization of alpha 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat.

Authors:  T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat.

Authors:  J Q Kong; D A Taylor; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

View more
  8 in total

1.  Removal of half the sympathetic innervation does not reduce vasoconstrictor responses in rat tail artery.

Authors:  Diana Tripovic; Elspeth M McLachlan; James A Brock
Journal:  J Physiol       Date:  2013-04-03       Impact factor: 5.182

2.  Evidence for involvement of alpha1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice.

Authors:  Joseph Zacharia; Chris Hillier; Akito Tanoue; Gozoh Tsujimoto; Craig J Daly; John C McGrath; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 3.  Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.

Authors:  Erika B Westcott; Steven S Segal
Journal:  Microcirculation       Date:  2013-04       Impact factor: 2.628

4.  The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes.

Authors:  L Methven; M McBride; G A Wallace; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-06-30       Impact factor: 8.739

5.  ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.

Authors:  Nataraj Brahmadevara; Angus M Shaw; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

6.  Smooth muscle alpha1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca2+ in hamster cremaster arterioles.

Authors:  W F Jackson; E M Boerman; E J Lange; S S Lundback; K D Cohen
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

7.  High vascular tone of mouse femoral arteries in vivo is determined by sympathetic nerve activity via α1A- and α1D-adrenoceptor subtypes.

Authors:  Joseph Zacharia; Joseph R H Mauban; Hema Raina; Steven A Fisher; Withrow G Wier
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

8.  Diminished neurogenic femoral artery vasoconstrictor response in a Zucker obese rat model: differential regulation of NOS and COX derivatives.

Authors:  Ana Cristina Martínez; Medardo Hernández; Susana Novella; María Pilar Martínez; Rosa María Pagán; Carlos Hermenegildo; Albino García-Sacristán; Dolores Prieto; Sara Benedito
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.